References
Huang CH, Mirabelli CK, Mong S, Crook ST: Intermolecular cross-linking of DNA through bifunctional intercalation of an antitumor antibiotic, luzopeptin A (BBM-928A). Cancer Res 43 (6): 2718–2724, 1983
Clinical Brochure, Echinomycin. Division of Cancer Treatment, 1981
Lathan B, Von Hoff D: Cytotoxic activity of echinomycin in a human tumor cloning system. Cancer Drug Deliv 1 (3): 191–198, 1984
Kuhn J, Von Hoff D, Schick M, Clark G, Kisner D, Weiss G, Melink T: Phase I trial of echinomycin (NSC 526417). Proc Am Soc Clin Oncol 3: 24, 1984
Haas C, Baker L, Leichman L, Decker D: Phase I evaluation of echinomycin administered on a weekly × 4 schedule. (Abstr) Proc Am Soc Clin Oncol 3: 29, 1984
Harvey JH, McFadden M, Andrews WG, Byrne PJ, Ahlgren JD, Woolley PV: Phase I study of echinomycin administered on an intermittent bolus schedule. Cancer Treat Rep 69 (12): 1365–1368, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hakes, T., Markman, M. & Phillips, M. A phase II trial of echinomycin in metastatic cervix carcinoma. Invest New Drugs 8, 311–312 (1990). https://doi.org/10.1007/BF00171844
Issue Date:
DOI: https://doi.org/10.1007/BF00171844